Zavain Dar

Insider Reports History

Entity
Individual
Location
C/O Lux Capital Management, Llc, 1600 El Camino Real Suite 290, Menlo Park, CA
Signature
/s/ Jonathan Golightly, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Zavain Dar:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. Director Class A Common Stock 108K $752K $6.95 Jan 2, 2025 Direct
RECURSION PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 26.2K Jun 3, 2024 Direct

Insider Reports Filed by Zavain Dar

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RXRX RECURSION PHARMACEUTICALS, INC. Jan 2, 2025 1 $0 4 Jan 6, 2025 Director
RXRX RECURSION PHARMACEUTICALS, INC. Oct 1, 2024 1 $0 4 Oct 4, 2024 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jul 1, 2024 1 $0 4 Jul 3, 2024 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jun 3, 2024 2 $0 4 Jun 5, 2024 Director
RXRX RECURSION PHARMACEUTICALS, INC. Apr 1, 2024 1 $0 4 Apr 3, 2024 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
RXRX RECURSION PHARMACEUTICALS, INC. Dec 14, 2023 1 -$181K 4 Dec 18, 2023 Director
RXRX RECURSION PHARMACEUTICALS, INC. Oct 2, 2023 1 $0 4 Oct 4, 2023 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jul 3, 2023 1 $0 4 Jul 6, 2023 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jun 16, 2023 2 $0 4 Jun 21, 2023 Director
RXRX RECURSION PHARMACEUTICALS, INC. Apr 3, 2023 1 $0 4/A Apr 28, 2023 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jul 8, 2022 1 $0 4 Jul 12, 2022 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
RXRX RECURSION PHARMACEUTICALS, INC. Dec 7, 2021 1 $0 4 Dec 9, 2021 Director